DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
D-FLUOROMETHYLTYROSINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
D-FLUOROMETHYLTYROSINE
×
Maximum Phase:
1
First Approval:
None
UNII:
GSM7N3U4J8
Molecule Type:
Small molecule
Molecular Formula:
C10H12FNO3
Molecular Weight:
213.21
AlogP:
0.95
PSA:
72.55
HBD:
2.0
HBA:
#RotB:
5.0
Source:
CONTELTINIB
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
ALK tyrosine kinase receptor inhibitor
CONTELTINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
URX2UMQ8XV
Molecule Type:
Small molecule
Molecular Formula:
C32H45N9O3S
Molecular Weight:
635.84
AlogP:
3.84
PSA:
126.99
HBD:
4.0
HBA:
#RotB:
10.0
Source:
GCC-4401C
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GCC-4401C
×
Maximum Phase:
1
First Approval:
None
UNII:
I636054KKA
Molecule Type:
Small molecule
Molecular Formula:
C18H18ClN5O3S
Molecular Weight:
419.89
AlogP:
2.51
PSA:
86.27
HBD:
2.0
HBA:
#RotB:
5.0
Source:
BMS-387032
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Mantle-Cell; Multiple Myeloma; Neoplasms
Cyclin-dependent kinase 2 inhibitor
BMS-387032
×
Maximum Phase:
1
First Approval:
None
UNII:
9979I93686
Molecule Type:
Small molecule
Molecular Formula:
C17H24N4O2S2
Molecular Weight:
380.54
AlogP:
3.66
PSA:
80.05
HBD:
2.0
HBA:
#RotB:
5.0
Source:
OBP-801
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
OBP-801
×
Maximum Phase:
1
First Approval:
None
UNII:
30Q3VS5HZ4
Molecule Type:
Small molecule
Molecular Formula:
C20H31N3O6S2
Molecular Weight:
473.62
AlogP:
0.52
PSA:
133.83
HBD:
4.0
HBA:
#RotB:
1.0
Source:
N6022
1
Small molecule
Investigational
Unknown
Unknown
Asthma; Cystic Fibrosis
Alcohol dehydrogenase class III inhibitor
N6022
×
Maximum Phase:
1
First Approval:
None
UNII:
80LIU5P95D
Molecule Type:
Small molecule
Molecular Formula:
C24H22N4O3
Molecular Weight:
414.47
AlogP:
3.75
PSA:
103.14
HBD:
2.0
HBA:
#RotB:
7.0
Source:
METHYL P-TOLUENESULFONYL-L-ARGININATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
METHYL P-TOLUENESULFONYL-L-ARGININATE
×
Maximum Phase:
1
First Approval:
None
UNII:
1H7BKF44U1
Molecule Type:
Small molecule
Molecular Formula:
C14H22N4O4S
Molecular Weight:
342.42
AlogP:
-0.13
PSA:
136.87
HBD:
3.0
HBA:
#RotB:
8.0
Source:
RG6029
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Sodium channel protein type IX alpha subunit blocker
RG6029
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CYCLOHEXANE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CYCLOHEXANE
×
Maximum Phase:
1
First Approval:
None
UNII:
48K5MKG32S
Molecule Type:
Small molecule
Molecular Formula:
C6H12
Molecular Weight:
84.16
AlogP:
2.34
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
0.0
Source:
FF-10101
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Tyrosine-protein kinase receptor FLT3 inhibitor
FF-10101
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C29H38N8O2
Molecular Weight:
530.68
AlogP:
3.13
PSA:
126.28
HBD:
3.0
HBA:
#RotB:
13.0
Source:
ROLUPERIDONE HYDROCHLORIDE
1
Small molecule
Investigational
Unknown
Unknown
Schizophrenia
Unknown
ROLUPERIDONE HYDROCHLORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
WFL7TF8DTP
Molecule Type:
Small molecule
Molecular Formula:
C22H28ClFN2O4
Molecular Weight:
438.93
AlogP:
3.38
PSA:
40.62
HBD:
0.0
HBA:
#RotB:
5.0
Source:
CROBENETINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CROBENETINE
×
Maximum Phase:
1
First Approval:
None
UNII:
Q72DWI2G4C
Molecule Type:
Small molecule
Molecular Formula:
C25H33NO2
Molecular Weight:
379.54
AlogP:
4.91
PSA:
32.7
HBD:
1.0
HBA:
#RotB:
5.0
Source:
CI-988
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Cholecystokinin B receptor antagonist
CI-988
×
Maximum Phase:
1
First Approval:
None
UNII:
2637PDX9SI
Molecule Type:
Small molecule
Molecular Formula:
C35H42N4O6
Molecular Weight:
614.74
AlogP:
4.86
PSA:
149.62
HBD:
5.0
HBA:
#RotB:
12.0
Source:
ASP-3026
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Follicular; Neoplasms
ALK tyrosine kinase receptor inhibitor
ASP-3026
×
Maximum Phase:
1
First Approval:
None
UNII:
HP4L6MXF10
Molecule Type:
Small molecule
Molecular Formula:
C29H40N8O3S
Molecular Weight:
580.76
AlogP:
3.77
PSA:
115.82
HBD:
2.0
HBA:
#RotB:
9.0
Source:
MK-8245
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
MK-8245
×
Maximum Phase:
1
First Approval:
None
UNII:
537E7QE8LX
Molecule Type:
Small molecule
Molecular Formula:
C17H16BrFN6O4
Molecular Weight:
467.26
AlogP:
2.36
PSA:
119.4
HBD:
1.0
HBA:
#RotB:
6.0
Source:
INDIGOTINDISULFONATE
1
Small molecule
Investigational
Unknown
Unknown
Brain Neoplasms
Unknown
INDIGOTINDISULFONATE
×
Maximum Phase:
1
First Approval:
None
UNII:
X7OI7JF73P
Molecule Type:
Small molecule
Molecular Formula:
C16H10N2O8S2
Molecular Weight:
422.4
AlogP:
1.31
PSA:
166.94
HBD:
4.0
HBA:
#RotB:
2.0
Source:
CIS-UROCANIC ACID
1
Small molecule
Investigational
Unknown
Unknown
Dry Eye Syndromes
Unknown
CIS-UROCANIC ACID
×
Maximum Phase:
1
First Approval:
None
UNII:
5LM7WD7VIC
Molecule Type:
Small molecule
Molecular Formula:
C6H6N2O2
Molecular Weight:
138.13
AlogP:
0.51
PSA:
65.98
HBD:
2.0
HBA:
#RotB:
2.0
Source:
L-377202
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Unknown
L-377202
×
Maximum Phase:
1
First Approval:
None
UNII:
VDXVABRQTV
Molecule Type:
Small molecule
Molecular Formula:
C65H89N9O25
Molecular Weight:
1396.46
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BMS-908662
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-908662
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NAPHTHALENE
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
NAPHTHALENE
×
Maximum Phase:
1
First Approval:
None
UNII:
2166IN72UN
Molecule Type:
Small molecule
Molecular Formula:
C10H8
Molecular Weight:
128.17
AlogP:
2.84
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
0.0
Source:
AS-602868
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor
AS-602868
×
Maximum Phase:
1
First Approval:
None
UNII:
Y1FZ8P93E0
Molecule Type:
Small molecule
Molecular Formula:
C18H14N4O3S
Molecular Weight:
366.4
AlogP:
3.01
PSA:
84.42
HBD:
1.0
HBA:
#RotB:
4.0
Source:
L-21649
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Vascular endothelial growth factor receptor inhibitor
L-21649
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VS-4718
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Biphenotypic, Acute; Leukemia, Myeloid, Acute; Pancreatic Neoplasms
Focal adhesion kinase 1 inhibitor
VS-4718
×
Maximum Phase:
1
First Approval:
None
UNII:
L2BD0MW4OL
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FK453
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Adenosine A1 receptor antagonist
FK453
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C23H25N3O2
Molecular Weight:
375.47
AlogP:
3.78
PSA:
57.84
HBD:
1.0
HBA:
#RotB:
5.0
Source:
FOSIFLOXURIDINE NAFALBENAMIDE
1
Small molecule
Investigational
Unknown
Unknown
Colorectal Neoplasms; Neoplasms
Unknown
FOSIFLOXURIDINE NAFALBENAMIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
4YO6QT3SZ9
Molecule Type:
Small molecule
Molecular Formula:
C29H29FN3O9P
Molecular Weight:
613.54
AlogP:
3.4
PSA:
158.18
HBD:
3.0
HBA:
#RotB:
11.0
Source:
AZD-8330
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Dual specificity mitogen-activated protein kinase kinase 1 inhibitor
AZD-8330
×
Maximum Phase:
1
First Approval:
None
UNII:
G4990BOZ66
Molecule Type:
Small molecule
Molecular Formula:
C16H17FIN3O4
Molecular Weight:
461.23
AlogP:
1.83
PSA:
92.59
HBD:
3.0
HBA:
#RotB:
6.0
Source:
MILCICLIB MALEATE
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
MILCICLIB MALEATE
×
Maximum Phase:
1
First Approval:
None
UNII:
82W826FL6S
Molecule Type:
Small molecule
Molecular Formula:
C29H36N8O5
Molecular Weight:
576.66
AlogP:
2.57
PSA:
91.21
HBD:
2.0
HBA:
#RotB:
4.0
Source:
TALETRECTINIB ADIPATE
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
TALETRECTINIB ADIPATE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C29H34FN5O5
Molecular Weight:
551.62
AlogP:
4.43
PSA:
77.47
HBD:
2.0
HBA:
#RotB:
7.0
Source:
DS-7423
1
Small molecule
Investigational
Unknown
Unknown
Colorectal Neoplasms; Endometrial Neoplasms
PI3-kinase class I inhibitor
DS-7423
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TCD-717
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Choline kinase alpha inhibitor
TCD-717
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FISOGATINIB
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular
Unknown
FISOGATINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
5Q7R99CKV2
Molecule Type:
Small molecule
Molecular Formula:
C24H24Cl2N4O4
Molecular Weight:
503.39
AlogP:
4.49
PSA:
94.6
HBD:
2.0
HBA:
#RotB:
7.0
Source:
RXDX-105
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RXDX-105
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZELOPRAZOLE SODIUM
1
Small molecule
Investigational
Unknown
Unknown
Gastroesophageal Reflux
Unknown
AZELOPRAZOLE SODIUM
×
Maximum Phase:
1
First Approval:
None
UNII:
KDJ60607ON
Molecule Type:
Small molecule
Molecular Formula:
C22H26N3NaO4S
Molecular Weight:
451.52
AlogP:
3.66
PSA:
86.33
HBD:
1.0
HBA:
#RotB:
6.0
Source:
CH5132799
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CH5132799
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
XANOMELINE
1
Small molecule
Investigational
Unknown
Unknown
Schizophrenia
Muscarinic acetylcholine receptor M1 agonist
XANOMELINE
×
Maximum Phase:
1
First Approval:
None
UNII:
9ORI6L73CJ
Molecule Type:
Small molecule
Molecular Formula:
C14H23N3OS
Molecular Weight:
281.43
AlogP:
3.22
PSA:
38.25
HBD:
0.0
HBA:
#RotB:
7.0
Source:
1
2
…
75
76
77
78
79
80
81
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA